Experiment summary for ENCSR897COL

doi:10.17989/ENCSR897COL

Summary

Status
released
Assay
Mint-ChIP-seq (Control Mint-ChIP-seq)
Control type
input library
Biosample summary
Homo sapiens activated T-cell male adult (38 years) treated with anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hours
Biosample Type
primary cell
Replication type
isogenic
Description
Control Mint-ChIP-seq on activated T-cell male adult (38 years)
Treatments
anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 (UniProtKB:P60568) for 24 hours
Nucleic acid type
DNA

Attribution

ENCODE4 project
Lab
Bradley Bernstein, Broad
Award
UM1HG009390 (Bradley Bernstein, Broad)
Project
ENCODE
External resources
Aliases
bradley-bernstein:Project Element 4886
Date submitted
May 1, 2020
Date released
August 4, 2020

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Library
12Homo sapiens male adult (38 years) activated T-cell primary cell treated with anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hoursENCBS833ENPENCLB468BAW
21Homo sapiens male adult (38 years) activated T-cell primary cell treated with anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hoursENCBS693BECENCLB554XYK
11Homo sapiens male adult (38 years) activated T-cell primary cell treated with anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hoursENCBS833ENPENCLB428WYW
22Homo sapiens male adult (38 years) activated T-cell primary cell treated with anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hoursENCBS693BECENCLB985WHC